OneDigital Investment Advisors LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the second quarter, Holdings Channel.com reports. The institutional investor acquired 1,863 shares of the company’s stock, valued at approximately $900,000.
A number of other institutional investors and hedge funds have also bought and sold shares of ALAB. Vanguard Group Inc. grew its holdings in shares of Astera Labs by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock worth $2,300,344,000 after purchasing an additional 84,365 shares during the last quarter. Atreides Management LP raised its holdings in Astera Labs by 108.9% in the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock valued at $368,890,000 after buying an additional 1,754,593 shares during the last quarter. State Street Corp boosted its position in Astera Labs by 32.5% during the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after buying an additional 760,358 shares during the period. Geode Capital Management LLC boosted its position in Astera Labs by 4.5% during the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock worth $403,598,000 after buying an additional 104,935 shares during the period. Finally, Fred Alger Management LLC grew its holdings in Astera Labs by 25.5% during the 4th quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock worth $321,855,000 after acquiring an additional 393,250 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.
Insider Activity
In other news, Director Manuel Alba sold 136,974 shares of Astera Labs stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the transaction, the director directly owned 1,287,524 shares of the company’s stock, valued at approximately $569,098,483.24. This trade represents a 9.62% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the completion of the transaction, the director directly owned 75,688 shares in the company, valued at $26,882,106.96. This represents a 11.67% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 631,979 shares of company stock worth $215,479,247. 10.40% of the stock is owned by insiders.
Astera Labs Stock Performance
Astera Labs (NASDAQ:ALAB – Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same period in the prior year, the firm posted $0.44 EPS. The company’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current year.
Wall Street Analyst Weigh In
Several research firms have recently issued reports on ALAB. Zacks Research raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Jefferies Financial Group boosted their price objective on shares of Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. Morgan Stanley increased their price objective on Astera Labs to $335.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Bank of America raised their target price on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research report on Tuesday, June 23rd. Finally, Needham & Company LLC lifted their target price on Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus price target of $333.00.
Read Our Latest Report on Astera Labs
About Astera Labs
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Stories
- Five stocks we like better than Astera Labs
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
